ENANTA PHARMACEUTICALS, INC (ENTA) Total liabilities 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) total liabilities at each fiscal year-end, per SEC filings.
$216.0MFY2025 · since FY2017: $25.0M → $216.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $216.0M | -12.8% |
| FY2024 | $247.8M | +0.9% |
| FY2023 | $245.5M | +354.1% |
| FY2022 | $54.1M | +37.4% |
| FY2021 | $39.4M | +28.8% |
| FY2020 | $30.6M | +11.8% |
| FY2019 | $27.3M | +33.0% |
| FY2018 | $20.5M | -17.7% |
| FY2017 | $25.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTA financial trends
ENTA RevenueENTA Net incomeENTA Net marginENTA Gross profitENTA Gross marginENTA Operating incomeENTA Operating marginENTA Operating cash flowENTA Free cash flowENTA Capital expendituresENTA Return on equityENTA Stock buybacksENTA Dividends paidENTA Total assetsENTA Shareholders’ equityENTA overview →